| Literature DB >> 32890985 |
Abraham Gila1, Araceli Sánchez-Ortiz2, Antonio Jiménez2, Gabriel Beltrán2.
Abstract
In this work, the effects of high power ultrasound treatment (40 kHz) on virgin olive oil (VOO) for different times (0, 15, 30 min) were studied, in order to verify if extent modifications in their chemical composition and thermal properties. The effects of the different ultrasound treatments on VOOs were determined considering the following parameters: quality index (free acidity, K232 and K270), lipid profile (fatty acids and triglycerides composition) minor components (phenols, tocopherols, pigments and volatiles) and thermal properties (crystallization and melting) by Differential Scanning Calorimetry (DSC). During the ultrasound treatments, bubbles growth was present in the VOO due to the phenomenon of cavitation and a slight increase of the temperature was observed. In general, the ultrasound treatments did not cause alterations on VOO parameters evaluated (oxidation state, lipid profile, minor components and thermal profiles). However, a slight decrease was observed in some volatile compounds.Entities:
Keywords: Differential scanning calorimetry; Fatty acids; Minor components; Ultrasound; Virgin olive oil quality; Volatile compounds
Mesh:
Substances:
Year: 2020 PMID: 32890985 PMCID: PMC7786558 DOI: 10.1016/j.ultsonch.2020.105320
Source DB: PubMed Journal: Ultrason Sonochem ISSN: 1350-4177 Impact factor: 7.491
Fig. 1Detail of bubbles growth in the oils during US treatment due to cavitation phenomenon.
Ultrasound effects on quality index and minor components of VOOs.
| VOO variety | Picual | Arbequina | ||||||
|---|---|---|---|---|---|---|---|---|
| US time (min) | 0 | 15 | 30 | 60 | 0 | 15 | 30 | 60 |
| Quality indices | ||||||||
| F.A (%) | 0.18 ± 0.01A | 0.19 ± 0.02A | 0.18 ± 0.01A | 0.18 ± 0.01A | 0.22 ± 0.01A | 0.22 ± 0.01A | 0.23 ± 0.01A | 0.22 ± 0.01A |
| K232 | 1.87 ± 0.01A | 1.88 ± 0.04A | 1.87 ± 0.01A | 1.91 ± 0.02A | 2.00 ± 0.08A | 2.04 ± 0.04A | 2.01 ± 0.02A | 2.03 ± 0.03A |
| K270 | 0.14 ± 0.00A | 0.14 ± 0.01A | 0.14 ± 0.01A | 0.15 ± 0.01A | 0.15 ± 0.01A | 0.14 ± 0.01A | 0.15 ± 0.01A | 0.15 ± 0.02A |
| Minor components | ||||||||
| Polyphenols [mg kg−1] | 473 ± 2.3A | 478.2 ± 5.0A | 478.6 ± 7.6A | 475.5 ± 6.0A | 358.1 ± 5.1 A | 345.6 ± 3.6 AB | 336.2 ± 6.4B | 343.8 ± 7.7 AB |
| Tocopherols T. [mg kg−1] | 308.9 ± 1.1A | 308.4 ± 1.7A | 312.5 ± 3.2A | 315.4 ± 2.3A | 309.7 ± 2.4A | 308.4 ± 1.6A | 310.3 ± 3.1A | 303.9 ± 1.1A |
| α-Tocopherol [mg kg−1] | 283.3 ± 0.8A | 282.4 ± 1.9A | 285.1 ± 2.1A | 286.8 ± 2.0A | 290.4 ± 1.7A | 289.2 ± 1.1A | 292 ± 1.1A | 287.8 ± 1.5A |
| β-Tocopherol [mg kg−1] | 6.9 ± 0.4B | 7.2 ± 0.5AB | 7.8 ± 0.5AB | 8.6 ± 0.6A | 10.6 ± 0.6A | 10.9 ± 0.5A | 10.3 ± 1.8A | 8.9 ± 0.2A |
| γ-Tocopherol [mg kg−1] | 18.6 ± 0.8 A | 18.9 ± 0.5A | 19.6 ± 1.3A | 20 ± 0.9A | 8.7 ± 0.4A | 8.3 ± 0.0A | 8 ± 0.7A | 7.2 ± 0.5A |
| Carotenoids p. [mg kg−1] | 7.3 ± 0.0A | 7.4 ± 0.1A | 7.4 ± 0.1A | 7.4 ± 0.1A | 8.5 ± 0.2A | 8.3 ± 0.2A | 8.6 ± 0.1A | 8.7 ± 0.2A |
| Chlorophyll | 19.5 ± 0.1 A | 19.6 ± 0.2 A | 19.6 ± 0.0 A | 19.7 ± 0.3 A | 21.6 ± 0.3 A | 20.9 ± 0.2B | 21.1 ± 0.1 AB | 21.3 ± 0.2AB |
*Mean ± sd (n = 3). Different letters in the same row and VOO variety indicate significant differences (P < 0.05) between the different times of US treatment.
Ultrasound effects on fatty acid composition and triacylglycerol profile of VOOs.
| VOO variety | Picual | Arbequina | ||
|---|---|---|---|---|
| US time (min) | 0 | 60 | 0 | 60 |
| Fatty Acids (%) | ||||
| C12:0 | <0.01 | <0.01 | <0.01 | <0.01 |
| C14:0 | 0.01 ± 0.00A | 0.01 ± 0.00A | 0.01 ± 0.00A | 0.01 ± 0.00A |
| C16:0 | 12.18 ± 0.02B | 12.37 ± 0.06A | 15.17 ± 0.18A | 15.28 ± 0.11A |
| C16:1 | 1.10 ± 0.01A | 1.16 ± 0.02A | 1.55 ± 0.03A | 1.57 ± 0.02A |
| C17:0 | 0.05 ± 0.00A | 0.05 ± 0.00A | 0.12 ± 0.00A | 0.12 ± 0.00A |
| C17:1 | 0.1 ± 0.00A | 0.1 ± 0.00A | 0.25 ± 0.00A | 0.25 ± 0.00A |
| C18:0 | 2.67 ± 0.00A | 2.65. ± 0.01A | 1.94 ± 0.02A | 1.94 ± 0.01A |
| C18:1 | 78.40 ± 0.02A | 78.22 ± 0.06B | 68.25 ± 0.14A | 68.12 ± 0.12A |
| C18:2 | 4.00 ± 0.03A | 4.02 ± 0.00A | 11.19 ± 0.04A | 11.19 ± 0.00A |
| C18:3 | 0.64 ± 0.01A | 0.64 ± 0.00A | 0.62 ± 0.01A | 0.62 ± 0.00A |
| C20:0 | 0.39 ± 0.00A | 0.38 ± 0.00B | 0.40 ± 0.02A | 0.40 ± 0.00A |
| C20:1 | 0.26 ± 0.00A | 0.26 ± 0.00A | 0.31 ± 0.01A | 0.31 ± 0.00A |
| C22:0 | 0.12 ± 0.00A | 0.10 ± 0.00B | 0.12 ± 0.01A | 0.13 ± 0.00A |
| C22:1 | <0.01 | <0.01 | <0.01 | <0.01 |
| C24:0 | 0.07 ± 0.00A | 0.06 ± 0.00A | 0.06 ± 0.01A | 0.06 ± 0.00A |
| TAGs (%) | ||||
| LLL | 0.06 ± 0.01A | 0.06 ± 0.01A | 0.16 ± 0.02A | 0.17 ± 0.00A |
| OLLn + PoLL | 0.20 ± 0.0A | 0.18 ± 0.01B | 0.32 ± 0.03A | 0.33 ± 0.01A |
| PLLn | 0.06 ± 0.01A | 0.05 ± 0.01A | 0.09 ± 0.00A | 0.10 ± 0.00A |
| OLL | 0.64 ± 0.01A | 0.65 ± 0.01A | 2.52 ± 0.03A | 2.55 ± 0.03A |
| OOLn + PoOL | 1.31 ± 0.01A | 1.33 ± 0.01A | 1.51 ± 0.03A | 1.47 ± 0.02A |
| PLL + PoPoO | 0.28 ± 0.00A | 0.27 ± 0.02A | 1.09 ± 0.04A | 1.14 ± 0.02A |
| POLn + PPoPo + PPoL | 0.67 ± 0.00A | 0.63 ± 0.02B | 0.89 ± 0.05A | 0.92 ± 0.02A |
| OOLn + LnPP | 6.26 ± 0.02A | 6.24 ± 0.05A | 13.70 ± 0.06A | 13.74 ± 0.01A |
| PoOO | 2.11 ± 0.02A | 2.11 ± 0.02A | 2.10 ± 0.03A | 2.12 ± 0.03A |
| SLL + PLO | 3.04 ± 0.04A | 3.01 ± 0.03A | 8.78 ± 0.05A | 8.80 ± 0.03A |
| PoOP + SPoL + SOLn + SPoPo | 0.98 ± 0.04A | 0.94 ± 0.01A | 1.42 ± 0.09A | 1.37 ± 0.00A |
| PLP | 0.25 ± 0.02A | 0.18 ± 0.06A | 1.33 ± 0.04A | 1.26 ± 0.07A |
| OOO + PoPP | 46.63 ± 0.03B | 47.05 ± 0.18A | 31.87 ± 0.29A | 31.80 ± 0.19A |
| SOL | 0.34 ± 0.02A | 0.37 ± 0.05A | 0.78 ± 0.09A | 0.78 ± 0.08A |
| POO | 26.08 ± 0.08A | 26.16 ± 0.08A | 24.29 ± 0.27A | 24.20 ± 0.08A |
| POP | 4.29 ± 0.05A | 4.19 ± 0.07A | 5.19 ± 0.11A | 5.26 ± 0.06A |
| SOO | 5.26 ± 0.02A | 5.21 ± 0.13A | 2.96 ± 0.04A | 2.88 ± 0.14A |
| POS + SLS | 1.33 ± 0.00A | 1.39 ± 0.04A | 1.12 ± 0.0A | 1.10 ± 0.06A |
*Mean ± sd (n = 3). Different letters in the same row and VOO variety indicate significant differences (P < 0.05) between the different times of US treatment.
Ultrasound effects on DSC parameters of the VOOs.
| VOO variety | Picual | Arbequina | ||||||
|---|---|---|---|---|---|---|---|---|
| US time (min) | 0 | 15 | 30 | 60 | 0 | 15 | 30 | 60 |
| Cooling treatment | ||||||||
| to (°C) | −15.4 ± 0.1A | −16.3 ± 0.2B | −16.6 ± 0.1B | −15.3 ± 0.4A | −13.1 ± 0.0B | −12.8 ± 0.4AB | −13.0 ± 0.0AB | −12.8 ± 0.1A |
| Pc (°C) | −41.4 ± 0.0A | −41.6 ± 0.1A | −41.6 ± 0.1A | −41.4 ± 0.1A | −47.2 ± 0.2A | −47.8 ± 0.3B | −47.2 ± 0.1A | −47.9 ± 0.1B |
| te (°C) | −47.0 ± 0.0A | −47.0 ± 0.2A | −47.2 ± 0.1A | −47.2 ± 0.1A | −54.9 ± 0.4A | −55.5 ± 1.0A | −55.2 ± 0.2A | −55.6 ± 0.3A |
| R | 31.7 ± 0.1AB | 30.7 ± 0.1BC | 30.6 ± 0.1C | 31.9 ± 0.5A | 41.7 ± 0.3A | 42.8 ± 0.5A | 42.2 ± 0.2A | 42.8 ± 0.4A |
| Heating treatment | ||||||||
| to (°C) | −19.0 ± 0.1A | −18.9 ± 0.0A | −18.9 ± 0.1A | −19.0 ± 0.1A | –22.7 ± 0.7BC | −21.7 ± 1.3A | –23.0 ± 0.1C | −21.6 ± 0.2AB |
| Pm1 (°C) | −2.7 ± 0.1A | −2.6 ± 0.0A | −2.5 ± 0.1A | −2.6 ± 0.3A | −4.5 ± 0.0A | −4.8 ± 0.2AB | −4.8 ± 0.1B | −4.9 ± 0.1B |
| Pm2 (°C) | 6.9 ± 0.0A | 6.8 ± 0.1A | 6.9 ± 0.0A | 6.9 ± 0.1A | 7.3 ± 0.0A | 7.2 ± 0.1 A | 7.2 ± 0.0A | 7.2 ± 0.1A |
| te (°C) | 10.2 ± 0.1A | 10.3 ± 0.2A | 10.1 ± 0.1A | 10.1 ± 0.0A | 10.5 ± 0.1A | 10.4 ± 0.1A | 10.5 ± 0.0A | 10.5 ± 0.1A |
| R | 29.2 ± 0.1A | 29.2 ± 0.2 A | 29.0 ± 0.1A | 29.1 ± 0.1A | 33.2 ± 0.7A | 32.2 ± 1.3A | 32.5 ± 0.1A | 32.1 ± 0.3A |
*Mean ± sd (n = 3). Different letters in the same row and VOO variety indicate significant differences (P < 0.05) between the different times of US treatment. Pc, temperature of the major peak of crystallization phase; Pm1, temperature of the major peak of melting phase; Pm2, temperature of the minor peak of melting phase; to and Te, initial and end temperature of the transition phase, respectively; R, range of the transition phase (temperature difference between to and te).
Fig. 2Ultrasound effects on VOOs phenolic compounds. Different letters for each VOO variety and the same phenol compound indicate significant differences (p = 0.05) between the different times of US treatment.
Fig. 3Ultrasound effects on VOOs volatile compounds. Different letters for each VOO variety and the same volatile compound indicate significant differences (p = 0.05) between the different times of US treatment.